Finance·Jul 3, 2026
Sun Pharmaceutical Posts 10.5% Quarterly Gain as India Pharma Rally Extends
The Mumbai-based drugmaker recorded positive returns across multiple timeframes, with trading volumes nearing recent averages amid sustained investor interest in Indian pharmaceutical equities.
By Priyanka V. Rao · 3 min ·
